Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

1 article from the last 30 days matching "artificial intelligence"

AdvocacyPRESS RELEASEMar 26

National Organization for Rare Disorders and OpenEvidence Partner to Bring AI-Powered Rare Disease Resources to Clinicians and Patients Worldwide

NORD and OpenEvidence announced a partnership to create AI-powered tools that help doctors and patients find reliable information about rare diseases. These tools will use artificial intelligence to organize and review medical information, making it easier for people with rare diseases to access trustworthy resources and get better care.

WHY IT MATTERSThis partnership expands access to expert-reviewed rare disease information through AI technology, potentially helping patients with any rare disease find accurate medical resources and connect with specialists more easily.
Good to knowRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases